Clinical Trial Update: Evaluating Conversational Artificial Intelligence for Depression Management [NA]

View source ↗

Summary

George Mason University is evaluating a conversational AI system for depression management in a clinical trial that is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: George Mason University | Conditions: Major Depressive Disorder (MDD) | NA | Status: NOT_YET_RECRUITING